Loading...
Mangoceuticals, Inc.
MGRX•NASDAQ
Healthcare
Medical - Healthcare Information Services
$1.73
$-0.02(-1.14%)
Mangoceuticals, Inc. (MGRX) Financial Performance & Income Statement Overview
Review Mangoceuticals, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-35.30%
↓ 35.30%
Operating Income Growth
13.53%
↑ 13.53%
Net Income Growth
5.50%
↑ 5.50%
Operating Cash Flow Growth
30.49%
↑ 30.49%
Operating Margin
-2046.24%
↓ 2046.24%
Gross Margin
57.65%
↑ 57.65%
Net Profit Margin
-2186.92%
↓ 2186.92%
ROE
-72.79%
↓ 72.79%
ROIC
-51.64%
↓ 51.64%
Mangoceuticals, Inc. (MGRX) Income Statement & Financial Overview
Review Mangoceuticals, Inc.'s (MGRX) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $86801.00 | $105247.00 | $133368.00 | $163163.00 |
| Cost of Revenue | $24737.00 | $25144.00 | $50697.00 | $93371.00 |
| Gross Profit | $62064.00 | $80103.00 | $82671.00 | $69792.00 |
| Gross Profit Ratio | $0.72 | $0.76 | $0.62 | $0.43 |
| R&D Expenses | $0.00 | $171861.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.82M | $1.74M | $1.59M | $2.20M |
| Operating Expenses | $4.89M | $1.76M | $1.84M | $2.24M |
| Total Costs & Expenses | $4.92M | $1.78M | $1.89M | $2.33M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$13700.00 | $0.00 | $241620.00 | $222678.00 |
| Depreciation & Amortization | $0.00 | -$9681.00 | $252.00 | $3205.00 |
| EBITDA | -$4.85M | -$1.68M | -$1.76M | -$2.17M |
| EBITDA Ratio | -$55.91 | -$15.94 | -$13.18 | -$13.27 |
| Operating Income | -$4.85M | -$1.68M | -$1.76M | -$2.17M |
| Operating Income Ratio | -$55.91 | -$15.94 | -$13.18 | -$13.29 |
| Other Income/Expenses (Net) | $13700.00 | -$270935.00 | -$241620.00 | -$222678.00 |
| Income Before Tax | -$4.84M | -$1.95M | -$2.00M | -$2.39M |
| Income Before Tax Ratio | -$55.75 | -$18.51 | -$14.99 | -$14.66 |
| Income Tax Expense | $0.00 | $40.00 | $0.00 | $0.00 |
| Net Income | -$4.84M | -$1.95M | -$2.00M | -$2.39M |
| Net Income Ratio | -$55.75 | -$18.51 | -$14.99 | -$14.65 |
| EPS | -$1.29 | -$0.98 | -$0.99 | -$1.37 |
| Diluted EPS | -$1.29 | -$0.98 | -$0.99 | -$1.37 |
| Weighted Avg Shares Outstanding | $4.59M | $1.98M | $2.01M | $1.74M |
| Weighted Avg Shares Outstanding (Diluted) | $4.59M | $1.98M | $2.01M | $1.74M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan